PL2358386T3 - Zoptymalizowane szczepionki na grypę - Google Patents

Zoptymalizowane szczepionki na grypę

Info

Publication number
PL2358386T3
PL2358386T3 PL09795684T PL09795684T PL2358386T3 PL 2358386 T3 PL2358386 T3 PL 2358386T3 PL 09795684 T PL09795684 T PL 09795684T PL 09795684 T PL09795684 T PL 09795684T PL 2358386 T3 PL2358386 T3 PL 2358386T3
Authority
PL
Poland
Prior art keywords
influenza vaccines
optimized influenza
optimized
vaccines
influenza
Prior art date
Application number
PL09795684T
Other languages
English (en)
Inventor
Anders Fomsgaard
Karoline Bragstad
Original Assignee
Statens Serum Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut filed Critical Statens Serum Institut
Publication of PL2358386T3 publication Critical patent/PL2358386T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL09795684T 2008-11-28 2009-11-27 Zoptymalizowane szczepionki na grypę PL2358386T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200801688 2008-11-28
EP09795684.1A EP2358386B1 (en) 2008-11-28 2009-11-27 Optimized influenza vaccines

Publications (1)

Publication Number Publication Date
PL2358386T3 true PL2358386T3 (pl) 2017-04-28

Family

ID=58773060

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09795684T PL2358386T3 (pl) 2008-11-28 2009-11-27 Zoptymalizowane szczepionki na grypę

Country Status (7)

Country Link
US (1) US9764024B2 (pl)
EP (1) EP2358386B1 (pl)
DK (1) DK2358386T3 (pl)
ES (1) ES2614802T3 (pl)
HU (1) HUE030520T2 (pl)
PL (1) PL2358386T3 (pl)
WO (1) WO2010060430A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8298820B2 (en) 2010-01-26 2012-10-30 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
US8935254B2 (en) * 2012-12-31 2015-01-13 Perinote LLC Methods and systems for organizing information
US9975925B2 (en) 2013-08-28 2018-05-22 Glaxosmithkline Biologicals S.A. Influenza antigens and antibodies
PL4023249T3 (pl) 2014-04-23 2025-03-10 Modernatx, Inc. Szczepionki z kwasem nukleinowym
JP7384512B2 (ja) * 2015-10-22 2023-11-21 モデルナティエックス インコーポレイテッド 広域インフルエンザウイルスワクチン
US20170322696A1 (en) 2016-05-07 2017-11-09 Perinote LLC Selecting and performing contextual actions via user interface objects
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
CN109678937B (zh) * 2017-10-18 2022-06-07 厦门大学 H3n2亚型流感病毒血凝素蛋白的突变体及其应用
US11389525B2 (en) 2017-10-27 2022-07-19 Statens Serum Institut Polygene influenza vaccine
WO2019121513A1 (en) 2017-12-18 2019-06-27 Intervet International B.V. Swine influenza a virus vaccine
US12521430B2 (en) 2018-03-28 2026-01-13 Sanofi Pasteur Inc. Methods of generating broadly protective vaccine compositions comprising neuraminidase
KR20230104068A (ko) * 2020-03-31 2023-07-07 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 뉴클레오사이드 변형 mRNA를 사용한 범용 인플루엔자 백신
CN117534737B (zh) * 2022-07-15 2024-09-06 中山大学·深圳 一种季节性甲型流感通用Mosaic重组抗原及其疫苗和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040087521A1 (en) * 1993-03-18 2004-05-06 Merck & Co., Inc. Nucleic acid pharmaceuticals-influenza matrix
US6649170B1 (en) 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
US20020165176A1 (en) * 2000-05-01 2002-11-07 Haynes Joel R. Nucleic acid immunization
WO2004006952A2 (en) 2002-07-13 2004-01-22 Statens Serum Institut Therapeutic tuberculosis vaccines
JP5331340B2 (ja) 2004-05-18 2013-10-30 バイカル インコーポレイテッド インフルエンザウィルスワクチン組成物、及びその使用方法
US7749520B2 (en) 2004-07-07 2010-07-06 Statens Serum Institut Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
WO2006063101A2 (en) 2004-12-09 2006-06-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Vaccines for the rapid response to pandemic avian influenza
GB0507997D0 (en) 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
EP2040745B1 (en) 2006-06-28 2012-12-05 Statens Serum Institut Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
WO2008021412A2 (en) * 2006-08-14 2008-02-21 Biorexis Pharmaceutical Corporation Interferon beta and transferrin fusion proteins
EP2160198A2 (en) 2007-05-31 2010-03-10 Statens Serum Institut Influenza vaccines
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
US20100015171A1 (en) 2008-07-15 2010-01-21 Statens Serum Institute Vaccines comprising tb 10.4
WO2010036970A2 (en) * 2008-09-25 2010-04-01 Fraunhofer Usa, Inc. Influenza vaccines, antigens, compositions, and methods

Also Published As

Publication number Publication date
US20110229518A1 (en) 2011-09-22
WO2010060430A2 (en) 2010-06-03
EP2358386A2 (en) 2011-08-24
EP2358386B1 (en) 2016-11-02
US9764024B2 (en) 2017-09-19
HUE030520T2 (en) 2017-05-29
ES2614802T3 (es) 2017-06-02
DK2358386T3 (en) 2017-02-13
WO2010060430A3 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
GB0810305D0 (en) Influenza vaccination
SI2185191T1 (sl) Cepiva proti influenci z majhnimi dodatki
IL211233A0 (en) Vaccine
IL208660A0 (en) Coccididosis vaccines
GB0905570D0 (en) Combined vaccines
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
ZA201007331B (en) Vaccine
GB0822001D0 (en) Vaccine
GB0810710D0 (en) Vaccine
GB0906234D0 (en) Vaccine
ZA201007402B (en) Vaccine
ZA201100889B (en) Vaccine against hpv
GB0918679D0 (en) Influenza vaccine
ZA201100962B (en) Influenza vaccines
GB0816447D0 (en) Vaccine
GB0816284D0 (en) Vaccine
GB0907935D0 (en) Vaccines
GB201000522D0 (en) Vaccine
GB0801326D0 (en) Vaccines
EP2240199A4 (en) INFLUENZA VACCINES
ZA201005238B (en) Canine influenza vaccines
GB0818459D0 (en) Vaccines
AU2008267307A1 (en) Vaccine
AP2010005295A0 (en) Vaccine
GB0806461D0 (en) Anti-atheroma vaccine